• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道对大鼠中 felodipine 首过代谢的贡献。

Contribution of the intestine to the first-pass metabolism of felodipine in the rat.

作者信息

Wang S X, Sutfin T A, Bäärnhielm C, Regårdh C G

机构信息

Hässle Cardiovascular Research Laboratories, Mölndal, Sweden.

出版信息

J Pharmacol Exp Ther. 1989 Aug;250(2):632-6.

PMID:2760845
Abstract

The systemic availability of intraduodenally (i.d.) administered felodipine in the rat is about 10%. The purpose of this study was to determine to what extent intestinal metabolism contributes to the first-pass elimination of felodipine in the rat. Four different types of experiments were performed. 1) [3H]Felodipine was given i.v. and i.p.; 2) the uptake of i.p. administered [3H]felodipine by the lymph was studied for 3 hr after dosing; 3) portal blood was collected quantitatively for 40 min after i.d. administration of [3H]felodipine; and 4) the in vitro metabolism of felodipine was studied in intestinal cell suspensions. The mean bioavailability of the i.p. dose was approximately 48%. The uptake via the lymph was negligible as an insignificant amount of the radioactive i.p. dose was recovered in lymph from a main lymph vessel in the peritoneal cavity. An average of 21 +/- 12% of given radioactive dose was recovered in portal blood during the first 40 min after i.d. dosing. The recovered radioactivity was to 40 to 70% due to felodipine and 9 to 16% was due to dehydro-felodipine. These results indicate that substantial first-pass elimination occurs in the intestine of the rat. Further support for gastrointestinal metabolism of felodipine in the rat was obtained from incubations with intestinal cells.

摘要

大鼠十二指肠内给予非洛地平后的系统利用率约为10%。本研究的目的是确定肠道代谢在多大程度上导致大鼠非洛地平的首过消除。进行了四种不同类型的实验。1)静脉注射和腹腔注射[3H]非洛地平;2)给药后3小时研究腹腔注射[3H]非洛地平的淋巴摄取情况;3)十二指肠内给予[3H]非洛地平后40分钟定量收集门静脉血;4)在肠细胞悬液中研究非洛地平的体外代谢。腹腔注射剂量的平均生物利用度约为48%。由于从腹腔主要淋巴管的淋巴中回收的放射性腹腔注射剂量微不足道,因此通过淋巴的摄取可忽略不计。十二指肠内给药后最初40分钟内,门静脉血中平均回收了21±12%的给药放射性剂量。回收的放射性物质中,40%至70%归因于非洛地平,9%至16%归因于脱氢非洛地平。这些结果表明,大鼠肠道中发生了大量的首过消除。用肠细胞进行孵育进一步支持了大鼠非洛地平的胃肠道代谢。

相似文献

1
Contribution of the intestine to the first-pass metabolism of felodipine in the rat.肠道对大鼠中 felodipine 首过代谢的贡献。
J Pharmacol Exp Ther. 1989 Aug;250(2):632-6.
2
Effects of biliary excretion on the disposition of felodipine and metabolites in the rat.胆汁排泄对大鼠体内非洛地平及其代谢物处置的影响。
Xenobiotica. 1987 Oct;17(10):1203-14. doi: 10.3109/00498258709167412.
3
Stereoselective first-pass metabolism of verapamil in the small intestine and liver in rats.
Drug Metab Dispos. 2008 Oct;36(10):2037-42. doi: 10.1124/dmd.107.020339. Epub 2008 Jul 10.
4
Pharmacokinetics and haemodynamic effects of felodipine as monotherapy in hypertensive patients.
Clin Invest Med. 1987 Sep;10(5):388-94.
5
Hepatic and intestinal first-pass effects of oltipraz in rats.奥替普拉在大鼠体内的肝脏和肠道首过效应。
Biopharm Drug Dispos. 2005 May;26(4):129-34. doi: 10.1002/bdd.439.
6
First-pass metabolism of pentamethylmelamine in the rat liver.五甲基三聚氰胺在大鼠肝脏中的首过代谢。
Cancer Res. 1985 Mar;45(3):983-6.
7
Determination of in vivo absorption, metabolism, and transport of drugs by the human intestinal wall and liver with a novel perfusion technique.采用新型灌注技术测定药物在人体肠壁和肝脏中的体内吸收、代谢及转运情况。
Clin Pharmacol Ther. 2001 Sep;70(3):217-27. doi: 10.1067/mcp.2001.117937.
8
Synthesis, biological evaluation, calcium channel antagonist activity, and anticonvulsant activity of felodipine coupled to a dihydropyridine-pyridinium salt redox chemical delivery system.非洛地平与二氢吡啶 - 吡啶鎓盐氧化还原化学递送系统偶联的合成、生物学评价、钙通道拮抗剂活性及抗惊厥活性
J Med Chem. 1996 Nov 8;39(23):4576-82. doi: 10.1021/jm960531r.
9
Effect of dexamethasone on the intestinal first-pass metabolism of indinavir in rats: evidence of cytochrome P-450 3A [correction of P-450 A] and p-glycoprotein induction .地塞米松对大鼠体内茚地那韦肠道首过代谢的影响:细胞色素P-450 3A[应为P-450 A的修正]和P-糖蛋白诱导的证据
Drug Metab Dispos. 1999 Oct;27(10):1187-93.
10
Biotransformation of felodipine in liver microsomes from rat, dog, and man.非洛地平在大鼠、犬和人的肝微粒体中的生物转化。
Drug Metab Dispos. 1986 Sep-Oct;14(5):613-8.

引用本文的文献

1
Prediction of hepatic clearance in human from in vitro data for successful drug development.从体外数据预测人体肝脏清除率以实现成功的药物开发。
AAPS J. 2009 Jun;11(2):262-76. doi: 10.1208/s12248-009-9103-6. Epub 2009 Apr 30.
2
Effects of liver disease on pharmacokinetics. An update.肝脏疾病对药代动力学的影响。最新进展。
Clin Pharmacokinet. 1999 Nov;37(5):399-431. doi: 10.2165/00003088-199937050-00004.
3
Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression.葡萄柚汁通过降低肠道CYP3A蛋白表达来提高非洛地平在人体中的口服生物利用度。
J Clin Invest. 1997 May 15;99(10):2545-53. doi: 10.1172/JCI119439.
4
Relationship between time of intake of grapefruit juice and its effect on pharmacokinetics and pharmacodynamics of felodipine in healthy subjects.健康受试者中葡萄柚汁摄入时间与其对非洛地平药代动力学和药效学影响的关系。
Eur J Clin Pharmacol. 1995;49(1-2):61-7. doi: 10.1007/BF00192360.
5
Grapefruit juice-felodipine interaction: reproducibility and characterization with the extended release drug formulation.葡萄柚汁与非洛地平的相互作用:缓释药物制剂的重现性及特性研究
Br J Clin Pharmacol. 1995 Aug;40(2):135-40.
6
Stereoselective pharmacokinetics of oral felodipine and nitrendipine in healthy subjects: correlation with nifedipine pharmacokinetics.健康受试者口服非洛地平和尼群地平的立体选择性药代动力学:与硝苯地平药代动力学的相关性
Eur J Clin Pharmacol. 1993;44(2):163-9. doi: 10.1007/BF00315475.
7
Grapefruit juice and drugs. How significant is the interaction?葡萄柚汁与药物。这种相互作用有多显著?
Clin Pharmacokinet. 1994 Feb;26(2):91-8. doi: 10.2165/00003088-199426020-00002.
8
Felodipine clinical pharmacokinetics.非洛地平的临床药代动力学。
Clin Pharmacokinet. 1991 Dec;21(6):418-30. doi: 10.2165/00003088-199121060-00003.